Sponsor pipeline

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) clinical trial pipeline

Get alerts when Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)'s trials change

155 active trials 101 recruiting 9 Phase 3 34 disease areas 16 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

11 trials changed in the last 30 days: 1 stopped, 2 with notable changes, 8 with minor changes only.

  1. Stopped

    Trial terminated

    Sponsor's reason: slow recruitment.

    Also in this update: Final enrollment: 235 participants (planned 608); Primary completion date changed from estimate of Mar 2026 to Aug 6, 2026

    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 3 NCT06051227 Registry history

    Updated

  2. Notable

    Primary completion pushed from Oct 1, 2027 to Mar 30, 2028

    Also in this update: Recruitment opened; Completion moved earlier from Oct 1, 2030 to Mar 30, 2030

    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Not specified NCT07208331 Registry history

    Updated

Show 8 trials with minor changes only
  1. Minor
    8 trials marked Unknown by the registry's verification sweep
    4. Minor

      Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting

      Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Not specified NCT06586268 Registry history

      Changed

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-09 NCT07867873 Surgery Versus Stereotactic Ablative Radiotherapy for Patients With Locally Advanced… Phase 3 Not Yet Recruiting
2026-09-23 NCT07837128 PERMISSive Lung-protective Ventilation RCT Recruiting

Active trials by phase

Early Phase 1
1
Phase 1/2
2
Phase 2
15
Phase 2/3
2
Phase 3
7
Phase 4
8
Not charted: 120 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 155

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06448676 Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides Wrinkle Recruiting 2026-08-14
NCT07760480 Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months… Lupus Nephritis Recruiting 2026-08-12
NCT05168462 Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood… Cardiogenic Shock Recruiting 2026-03-27
NCT07262957 Preventing Postoperative Complications in Patients Undergoing High-risk… Pancreas Head Cancer Recruiting 2025-12-22
NCT06004986 DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema Atopic Dermatitis Recruiting 2025-10-08
NCT04073290 Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and… Hepatic Encephalopathy Recruiting 2025-01-28
NCT07689279 Selection of Transcatheter Heart vaLve With Intermediate Sizing in Patients With Severe… Aortic Stenosis, Severe Not Yet Recruiting 2026-07-08
NCT05804097 Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently? Peripheral Vascular Disease Active, Not Recruiting 2024-11-08
Phase 3
NCT07359482 sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19 Post-COVID Recruiting 2026-06-09
NCT06059989 InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease Inflammatory Disease Recruiting 2024-12-10
NCT03582293 Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma Hematoma, Subdural, Chronic Recruiting 2024-06-20
NCT05188313 TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer Esophageal Cancer Recruiting 2022-06-24
NCT07867873 Surgery Versus Stereotactic Ablative Radiotherapy for Patients With Locally Advanced… Locally Advanced Pancreatic Carcinoma (LAPC) Not Yet Recruiting 2026-10-09
NCT06263244 Specifying the Anti-inflammatory Effects of Ziltivekimab Atherosclerosis Active, Not Recruiting 2026-08-06
NCT03413254 Second and Third Look Laparoscopy in pT4 Colon Cancer Patients for Early Detection of… Colorectal Cancer Active, Not Recruiting 2024-02-23
Phase 2/3
NCT06672887 Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers… Cancer Recruiting 2024-11-04
NCT05832034 Add-on Intravenous Immunoglobulins in Early Myositis Inflammatory Myopathy, Idiopathic Active, Not Recruiting 2026-02-27
Phase 2
NCT07000253 Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in… Esophageal Cancer Recruiting 2026-09-10
NCT07632079 Hypofractionated Definitive Chemoradiotherapy for Oesophageal Cancer Locally Advanced Esophageal or GE Junction Cancer Recruiting 2026-06-08
NCT05439031 StereoTactic Arrhythmia Radiotherapy in the NetherLands no. 2 Ventricular Tachycardia Recruiting 2026-01-14
NCT07316127 Immunoadsorption in Autoimmune Long COVID Long COVID Recruiting 2026-01-05
NCT07083882 Faecal Autologous Capsule Transplantation for Type 1 Diabetes Mellitus Type 1 Diabetes Mellitis Recruiting 2025-07-24
NCT06940011 Endocalyx in Treatment Resistent Hypertension Treatment Resistant Hypertension Recruiting 2025-04-23
NCT04507178 Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine Aneurysmal Subarachnoid Hemorrhage Recruiting 2025-01-29
NCT05177133 Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer… Gastric Adenocarcinoma Recruiting 2024-08-02
See all 155 active Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) trials with filters →

Disease areas by active trials, top 10 of 34

Esophageal Cancer (11) · Coronary Artery Disease (7) · Diabetes (6) · Heart Disease (6) · Pancreatic Cancer (6) · Type 1 Diabetes (4) · Atopic Dermatitis (3) · Crohn's Disease (3) · Parkinson's Disease (3) · Prostate Cancer (3)

Get alerts when Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free